BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15185744)

  • 1. The role of protein misfolding in the pathogenesis of human diseases.
    Ellisdon AM; Bottomley SP
    IUBMB Life; 2004 Mar; 56(3):119-23. PubMed ID: 15185744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein misfolding and degradation in genetic diseases.
    Bross P; Corydon TJ; Andresen BS; Jørgensen MM; Bolund L; Gregersen N
    Hum Mutat; 1999; 14(3):186-98. PubMed ID: 10477427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease II: cellular protein quality control.
    Outeiro TF; Tetzlaff J
    Semin Pediatr Neurol; 2007 Mar; 14(1):15-25. PubMed ID: 17331880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG
    Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disordered proteins: biological membranes as two-dimensional aggregation matrices.
    Byström R; Aisenbrey C; Borowik T; Bokvist M; Lindström F; Sani MA; Olofsson A; Gröbner G
    Cell Biochem Biophys; 2008; 52(3):175-89. PubMed ID: 18975139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid peptides and proteins in review.
    Harrison RS; Sharpe PC; Singh Y; Fairlie DP
    Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the mysteries of protein folding and misfolding.
    Ecroyd H; Carver JA
    IUBMB Life; 2008 Dec; 60(12):769-74. PubMed ID: 18767168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein misfolding and human disease.
    Gregersen N; Bross P; Vang S; Christensen JH
    Annu Rev Genomics Hum Genet; 2006; 7():103-24. PubMed ID: 16722804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conformational diseases].
    Gregersen N; Bross P; Bolund LA
    Ugeskr Laeger; 2003 Feb; 165(8):801-5. PubMed ID: 12625122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A universal method for detection of amyloidogenic misfolded proteins.
    Yam AY; Wang X; Gao CM; Connolly MD; Zuckermann RN; Bleu T; Hall J; Fedynyshyn JP; Allauzen S; Peretz D; Salisbury CM
    Biochemistry; 2011 May; 50(20):4322-9. PubMed ID: 21539296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome.
    Masters SL; O'Neill LA
    Trends Mol Med; 2011 May; 17(5):276-82. PubMed ID: 21376667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can misfolded proteins be beneficial? The HAMLET case.
    Pettersson-Kastberg J; Aits S; Gustafsson L; Mossberg A; Storm P; Trulsson M; Persson F; Mok KH; Svanborg C
    Ann Med; 2009; 41(3):162-76. PubMed ID: 18985467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein misfolding disorders and rational design of antimisfolding agents.
    Estrada LD; Yowtak J; Soto C
    Methods Mol Biol; 2006; 340():277-93. PubMed ID: 16957342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.